Tacroheal 0.5 mg is a low-dose formulation of Tacrolimus, ideal for initial dosing or dose adjustments in transplant patients. It suppresses T-cell activation to reduce the immune system’s ability to reject the transplanted organ. Often used in combination with other immunosuppressants, this dose allows for fine-tuning to minimize side effects. Side effects may include headache, increased blood sugar, or tremors. Regular lab monitoring is essential. Always take on an empty stomach, and avoid grapefruit or herbal supplements unless approved by your physician.
There are no reviews yet.